HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia.

Abstract
The aim of this open-label, 8-week observational trial was to investigate the efficacy of Meta050 (a proprietary, standardized combination of reduced iso-alpha-acids from hops, rosemary extract and oleanolic acid) on pain in patients with rheumatic disease. Osteoarthritis, rheumatoid arthritis and fibromyalgia patients were given 440 mg Meta050 three times a day for 4 weeks, which was changed to 880 mg twice a day for the subsequent 4 weeks in the majority of patients. Pain and condition-specific symptoms were assessed using a standard visual analog scale (VAS), an abridged arthritis impact measurement scale (AIMS2) and the fibromyalgia impact questionnaire. Fifty-four subjects with rheumatic disease completed the trial. Following treatment, a statistically significant decrease in pain of 50% and 40% was observed in arthritis subjects using the VAS (p < 0.0001; Wilcoxon-ranked sums) and AIMS2 (p < 0.0001), respectively. Fibromyalgia subject scores did not significantly improve. A decreasing trend of C-reactive protein, a marker for inflammation, was also observed in those subjects who presented with elevated C-reactive protein. No serious side effects were observed. These observations suggest that Meta050 at a dosage of 440 mg three times a day has a beneficial effect on pain in arthritis subjects.
AuthorsDaniel Lukaczer, Gary Darland, Matthew Tripp, DeAnn Liska, Robert H Lerman, Barbara Schiltz, Jeffrey S Bland
JournalPhytotherapy research : PTR (Phytother Res) Vol. 19 Issue 10 Pg. 864-9 (Oct 2005) ISSN: 0951-418X [Print] England
PMID16261517 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2005 John Wiley & Sons, Ltd.
Chemical References
  • Antirheumatic Agents
  • Plant Extracts
  • Oleanolic Acid
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Antirheumatic Agents (administration & dosage, therapeutic use)
  • Arthritis, Rheumatoid (drug therapy, pathology)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Fibromyalgia (drug therapy, pathology)
  • Humans
  • Humulus
  • Male
  • Middle Aged
  • Olea
  • Oleanolic Acid (administration & dosage, therapeutic use)
  • Osteoarthritis (drug therapy, pathology)
  • Pain Measurement
  • Phytotherapy
  • Pilot Projects
  • Plant Extracts (administration & dosage, therapeutic use)
  • Rosmarinus
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: